Showing results (171-180 of 3,489) with videos related to
Sort By:
Pageof 349
Archiv Der Pharmazie|August 20, 2015
Synthesis of Tolmetin Hydrazide-Hydrazones and Discovery of a Potent Apoptosis Inducer in Colon Cancer CellsŞ Güniz Küçükgüzel, Derya Koç, Pelin Çıkla-Süzgün, et al.Archiv Der Pharmazie|November 3, 2015
Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-onePaula Zaręba, Magdalena Dudek, Klaudia Lustyk, et al.Archiv Der Pharmazie|May 14, 2019
Synthesis and antiageing properties of antioxidant pseudopeptides designed based on the bioisostere principleYanbing Li, Chao Zhang, Huailing Wang, et al.Archiv Der Pharmazie|April 27, 2019
Synthesis, docking studies, and pharmacological evaluation of 5HT2C ligands containing the N'-cyanoisonicotinamidine or N'-cyanopicolinamidine nucleusElisa Magli, Ewa Kędzierska, Agnieszka A Kaczor, et al.Archiv Der Pharmazie|June 9, 2018
Synthesis and glutathione reductase inhibitory properties of 5-methyl-2,4-dihydro-3H-1,2,4-triazol-3-one's aryl Schiff base derivativesHalis Türker Balaydın, Musa Özil, Murat ŞentürkArchiv Der Pharmazie|May 10, 2018
Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitorsZhen Zhang, Daoguang Zhang, Yang Liu, et al.Archiv Der Pharmazie|May 10, 2018
Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agentsAvneet Kaur, Dharam P Pathak, Vidushi Sharma, et al.Archiv Der Pharmazie|April 20, 2018
Molecular insights into trypanothione reductase-inhibitor interaction: A structure-based reviewNeha Tiwari, Neetu Tanwar, Manoj MundeArchiv Der Pharmazie|October 26, 2021
2-Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitorsLaura Schäkel, Salahuddin Mirza, Markus Pietsch, et al.Archiv Der Pharmazie|October 1, 2021
Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitorsKhaled El-Adl, Mohamed K Ibrahim, Fathalla Khedr, et al.Pageof 349